Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTHCARE CORPNHC · Entity 355 | Senior VP & General Counsel | September 10, 2026 | September 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTHCARE CORP
Report date September 10, 2026 · Filed September 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,127 |
Reported balance
After 2026-09-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-10 · Sale · Disposed 571 · Balance 12,127 F1: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.31 to $223.21, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. |
| Common StockSEC Table I · non-derivative | Direct | 11,338 |
Reported balance
After 2026-09-10 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-10 · Sale · Disposed 789 · Balance 11,338 F2: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.35 to $224.15, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. |
| Common StockSEC Table I · non-derivative | Direct | 10,047 |
Reported balance
After 2026-09-10 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2026-09-10 · Sale · Disposed 1,291 · Balance 10,047 F3: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.56 to $225.515, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. |
| Common StockSEC Table I · non-derivative | Direct | 9,979 |
Reported balance
After 2026-09-10 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2026-09-10 · Sale · Disposed 68 · Balance 9,979 F4: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.565 to $225.60, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. F5: Total amount of shares beneficially owned following transactions reported on this form. |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $53.94 · Expires 2028-03-08 | Direct | 4,000 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 4,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $94.10 · Expires 2029-03-05 | Direct | 8,000 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 8,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $90.62 · Expires 2030-02-24 | Direct | 9,000 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 9,000 |
| Option to Purchase Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $157.13 · Expires 2031-02-23 | Direct | 14,000 |
Reported balance
Holding disclosure · report date 2026-09-10 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 14,000 |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.31 to $223.21, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.35 to $224.15, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F3: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.56 to $225.515, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F4: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.565 to $225.60, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F5: Total amount of shares beneficially owned following transactions reported on this form.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 10, 2026 Filed Sep 14, 2026 20:36 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 68 | $225.59 | $15,339.87 |
DisclosureSEC source: 0001437749-26-030334 · rdgdoc.xml · nonDerivative · entry 4 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,979 F4 · price: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.565 to $225.60, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. F5 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:36 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 1,291 | $225.09 | $290,587.32 |
DisclosureSEC source: 0001437749-26-030334 · rdgdoc.xml · nonDerivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,047 F3 · price: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $224.56 to $225.515, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:36 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 789 | $223.78 | $176,560.84 |
DisclosureSEC source: 0001437749-26-030334 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,338 F2 · price: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.35 to $224.15, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 10, 2026 Filed Sep 14, 2026 20:36 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | SaleCommon Stock | 571 | $222.73 | $127,181.23 |
DisclosureSEC source: 0001437749-26-030334 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,127 F1 · price: The price reported in Column 4 above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.31 to $223.21, inclusive. The reporting person undertakes to provide, upon request by the Staff of the Securities and Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:26 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,500 | $0.00 Strike: $90.62 | $0.00 |
DisclosureSEC source: 0001437749-26-007211 · rdgdoc.xml · derivative · entry 5 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 13,500 shares Expires 2030-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:26 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 3,202 | $172.83 | $553,401.66 |
DisclosureSEC source: 0001437749-26-007211 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,698 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| March 04, 2026 Filed Mar 6, 2026 21:26 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 4,500 | $90.62 | $407,790.00 |
DisclosureSEC source: 0001437749-26-007211 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 27, 2026 Filed Mar 3, 2026 21:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 1,458 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-26-006611 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,400 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2027, the next 33 1/3% vesting on 1/1/2028, and the final 33 1/3% vesting on 1/1/2029. Read SEC document |
| February 23, 2026 Filed Feb 25, 2026 22:24 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 14,000 | $0.00 Strike: $157.13 | $0.00 |
DisclosureSEC source: 0001437749-26-005667 · rdgdoc.xml · derivative · entry 5 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-02-23 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:15 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-25-034894 · rdgdoc.xml · derivative · entry 4 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 12,000 shares Expires 2029-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:15 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 3,278 | $132.20 | $433,351.60 |
DisclosureSEC source: 0001437749-25-034894 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,438 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 22:15 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 4,000 | $94.10 | $376,400.00 |
DisclosureSEC source: 0001437749-25-034894 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,716 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 11, 2025 Filed Jan 5, 2026 22:02 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 496 | $137.90 | $68,398.40 |
DisclosureSEC source: 0001437749-26-000394 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,942 F1 · shares: On 1/1/2026, 33 1/3 (or 1162 shares) of restricted stock originally granted on 3/8/2023, 3/5/2024, and 3/5/2025 vested. The Company withheld 496 shares to pay tax obligations. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-25-027144 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 8,000 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 2,737 | $108.82 | $297,840.34 |
DisclosureSEC source: 0001437749-25-027144 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,716 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| August 13, 2025 Filed Aug 15, 2025 20:28 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 4,000 | $53.94 | $215,760.00 |
DisclosureSEC source: 0001437749-25-027144 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,453 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,734 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-25-020002 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,734 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 2,805 | $106.10 | $297,610.50 |
DisclosureSEC source: 0001437749-25-020002 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,453 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported for this Title of Securities on this form. Read SEC document |
| June 06, 2025 Filed Jun 10, 2025 20:54 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionCommon Stock | 3,734 | $63.96 | $238,826.64 |
DisclosureSEC source: 0001437749-25-020002 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 05, 2025 Filed Mar 6, 2025 23:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantCommon Stock | 1,385 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-006508 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,524 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2026, the next 33 1/3% vesting on 1/1/2027, and the final 33 1/3% vesting on 1/1/2028. Read SEC document |
| February 24, 2025 Filed Feb 26, 2025 22:40 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 13,500 | $0.00 Strike: $90.62 | $0.00 |
DisclosureSEC source: 0001437749-25-005279 · rdgdoc.xml · derivative · entry 5 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2030-02-24 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 24, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 24, 2026; one-third (1/3) will vest on February 24, 2027; and the final one-third (1/3) will vest on February 24, 2028. Read SEC document |
| January 01, 2025 Filed Jan 3, 2025 21:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingCommon Stock | 571 | $107.56 | $61,416.76 |
DisclosureSEC source: 0001437749-25-000227 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,139 F1 · shares: On 1/1/2025, 33 1/3 (or 1,338 shares) of restricted stock originally granted on 2/25/2022, 3/8/2023, and 3/5/2024 vested. The Company withheld 571 shares to pay tax obligations. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 4,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-24-020219 · rdgdoc.xml · derivative · entry 4 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 12,000 shares Expires 2028-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 2,799 | $103.61 | $290,004.39 |
DisclosureSEC source: 0001437749-24-020219 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,710 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| June 12, 2024 Filed Jun 13, 2024 22:16 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 4,000 | $53.94 | $215,760.00 |
DisclosureSEC source: 0001437749-24-020219 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,509 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $94.10 | $0.00 |
DisclosureSEC source: 0001437749-24-006984 · rdgdoc.xml · derivative · entry 4 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-03-05 F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 5, 2025; one-third (1/3) will vest on March 5, 2026; and the final one-third (1/3) will vest on March 5, 2027. Read SEC document |
| March 05, 2024 Filed Mar 7, 2024 21:56 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 1,375 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006984 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,509 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2025, the next 33 1/3% vesting on 1/1/2026, and the final 33 1/3% vesting on 1/1/2027. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 22:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-24-006439 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,734 Underlying: Common Stock · 7,467 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 22:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 2,911 | $98.66 | $287,199.26 |
DisclosureSEC source: 0001437749-24-006439 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,134 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| February 29, 2024 Filed Mar 4, 2024 22:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 3,733 | $63.96 | $238,762.68 |
DisclosureSEC source: 0001437749-24-006439 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 22:44 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 410 | $92.42 | $37,892.20 |
DisclosureSEC source: 0001437749-24-000459 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,312 F1 · shares: On 1/1/2024, 33 1/3 (or 1,090 shares) of restricted stock originally granted on 2/24/2021, 2/25/2022, and 3/8/2023 vested. The Company withheld 410 shares to pay tax obligations. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 22:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionOption to Purchase Common Stock · Derivative | 3,733 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-23-032915 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,467 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 22:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 3,296 | $77.33 | $254,879.68 |
DisclosureSEC source: 0001437749-23-032915 · rdgdoc.xml · nonDerivative · entry 2 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,722 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions on this form. Read SEC document |
| November 21, 2023 Filed Nov 22, 2023 22:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Exercise / conversionShares of Common Stock | 3,733 | $63.96 | $238,762.68 |
DisclosureSEC source: 0001437749-23-032915 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,018 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:17 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006025 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:17 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 728 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006025 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,285 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:20 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 297 | $59.50 | $17,671.50 |
DisclosureSEC source: 0001437749-23-000351 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,557 F1 · shares: On 1/1/2023, 33 1/3 (or 1,002 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 297 to pay tax obligations. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 20:39 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004821 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,854 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004199 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 22:35 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 108 | $67.94 | $7,337.52 |
DisclosureSEC source: 0001437749-22-000200 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946 F1 · shares: On 1/1/2022, 33 1/3 (or 367 shares) of restricted stock originally granted on 2/21/2020 and 2/24/2021 vested. The Company withheld 108 shares to pay tax obligations. Read SEC document |
| February 24, 2021 Filed Feb 26, 2021 16:53 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 633 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-004193 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,054 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2022, the next 33 1/3% vesting on 1/1/2023, and the final 33 1/3% vesting on 1/1/2024. Read SEC document |
| January 01, 2021 Filed Jan 8, 2021 20:35 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | Tax withholdingShares of Common Stock | 46 | $66.41 | $3,054.86 |
DisclosureSEC source: 0001437749-21-000405 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 421 F1 · shares: On 1/1/2021, 33 1/3 (or 156 shares) of restricted stock originally granted on 2/21/2020 vested. The Company withheld 46 shares to pay tax obligations. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:05 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantShares of Common Stock | 467 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-20-003492 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 467 F1 · shares: Restricted shares subject to a three-year vesting schedule. The shares will vest 33 1/3% on 1/1/2021, 66 2/3% on 1/1/2022, and 100% on 1/1/2023. Read SEC document |
| January 31, 2020 Filed Feb 4, 2020 17:25 UTC | NATIONAL HEALTHCARE CORP NHC · Entity 355 | GrantOption to Purchase Common Stock · Derivative | 24,000 | $0.00 Strike: $83.92 | $0.00 |
DisclosureSEC source: 0001437749-20-001634 · rdgdoc.xml · derivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2022-03-11 F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive Plan on January 31, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.